Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
Femasys Inc. (FEMY)
Company Research
Source: GlobeNewswire
ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the commercial launch of FemaSeed Complete, a comprehensive fertility solution that enables OB/GYNs to perform first-line insemination entirely within their own practices. An estimated 10 million women in the United States experience infertility, yet fewer than half access care, and only a very small percentage ultimately undergo IVF. At the same time, U.S. fertility rates declined again in 2025 to a record low, underscoring the growing need for earlier intervention and expanded access to care. While more than 40,000 OB/GYNs are accessible to patients, infertility specialists—fewer than 2,000 nationwide—are typically accessed by referral and concentrated in a declining number of centers, limiting access to treatment. By enabling first-line t
Show less
Read more
Impact Snapshot
Event Time:
FEMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FEMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FEMY alerts
High impacting Femasys Inc. news events
Weekly update
A roundup of the hottest topics
FEMY
News
- Femasys Drives International Growth with Israeli Market Entry for Fertility PortfolioGlobeNewswire
- Femasys appoints John Canning as COO [Seeking Alpha]Seeking Alpha
- Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial GrowthGlobeNewswire
- Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update [TheStreet.com]TheStreet.com
- Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate UpdateGlobeNewswire
FEMY
Sec Filings
- 4/6/26 - Form DEF
- 4/1/26 - Form 4
- 4/1/26 - Form 3
- FEMY's page on the SEC website